PHARMACOTHERAPY PROBLEMS IN COMMUNITY-ACQUIRED PNEUMONIA TREATMENT

Treatment of patients with CAP group II is an outpatient, patients receiving antibiotics per os. Aminopenicillines ( with clavulonate) or cephalosporins are combined with macrolides (azithromycin) in the treatment. Evaluation of the effectiveness of emergency treatment in all cases assessed within 48 hours of treatment. Clinical improvement observed in 90% of empiric therapy. Note that related conditions do not affect the choice of antibiotic therapy. Antibacterial therapy is directed against the pathogen (typical and atypical) and not against the related factors. Comorbidity is an important prognostic factor and influences the severity index of community acquired pneumonia, but does not play a role in the choice of antibiotic.